People with neuromyelitis optica spectrum disorder (NMOSD) may experience gradual shrinkage, or atrophy, of the brain even during periods without relapses, according to a new study that challenges the long-held view that most neurological damage in NMOSD occurs mainly during relapses. The researchers also found that starting biologic therapies earlier…